SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001564590-21-049295
Filing Date
2021-09-29
Accepted
2021-09-28 18:16:43
Documents
111
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 40-F/A ipa-40fa_20210430.htm 40-F/A 55630
  Complete submission text file 0001564590-21-049295.txt   13348940

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ipa-20210430.xml EX-101.INS 4745087
3 XBRL TAXONOMY EXTENSION SCHEMA ipa-20210430.xsd EX-101.SCH 133963
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipa-20210430_cal.xml EX-101.CAL 87040
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipa-20210430_def.xml EX-101.DEF 411115
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipa-20210430_lab.xml EX-101.LAB 727441
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipa-20210430_pre.xml EX-101.PRE 618857
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 40-F/A | Act: 34 | File No.: 001-39530 | Film No.: 211288739
SIC: 2834 Pharmaceutical Preparations